Q4 2022 Holdings
Filed 2023-02-14 | 79 holdings | $355.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $47.0M | 566,000 | 13.2% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $28.3M | 13,680,554 | 8.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.9M | 130,212 | 4.5% |
| Karuna Therapeutics Inc | COM | 48576A100 | $14.2M | 72,027 | 4.0% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $13.5M | 102,500 | 3.8% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $13.0M | 605,975 | 3.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $12.5M | 316,092 | 3.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $11.4M | 261,235 | 3.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $11.4M | 477,785 | 3.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $11.4M | 447,073 | 3.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.7M | 73,121 | 2.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $8.5M | 468,358 | 2.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $8.4M | 183,995 | 2.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $7.6M | 67,552 | 2.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.9M | 180,306 | 1.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $6.9M | 766,843 | 1.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $6.2M | 566,695 | 1.8% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $5.6M | 631,554 | 1.6% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $5.6M | 550,940 | 1.6% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $5.5M | 393,113 | 1.5% |
| Morphic Holding Inc | COM | 61775R105 | $5.2M | 195,467 | 1.5% |
| Alector Inc(ALEC) | COM | 014442107 | $4.9M | 532,438 | 1.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.9M | 521,553 | 1.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.3M | 83,446 | 1.2% |
| Merus N V | COM | N5749R100 | $4.2M | 269,893 | 1.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.2M | 616,032 | 1.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.1M | 324,173 | 1.2% |
| Cardiovascular Systems(CSIIEUR) | COM | 141619106 | $3.9M | 286,988 | 1.1% |
| Dice Therapeutics Inc | COM | 23345J104 | $3.9M | 123,500 | 1.1% |
| F-Star Therapeutics Inc | COM | 30315R107 | $3.6M | 576,881 | 1.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $3.6M | 122,200 | 1.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.3M | 73,600 | 0.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $3.3M | 332,103 | 0.9% |
| Atricure Inc(ATRC) | COM | 04963C209 | $3.2M | 72,029 | 0.9% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $3.0M | 602,051 | 0.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $2.9M | 142,217 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.9M | 251,000 | 0.8% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $2.8M | 204,082 | 0.8% |
| Accuray Inc(ARAY) | COM | 004397105 | $2.6M | 1,222,358 | 0.7% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.4M | 475,367 | 0.7% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.4M | 413,463 | 0.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.3M | 52,675 | 0.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.2M | 1,176,150 | 0.6% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $2.2M | 313,717 | 0.6% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $2.1M | 168,846 | 0.6% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $2.0M | 473,136 | 0.6% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.9M | 98,560 | 0.5% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.8M | 144,784 | 0.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.6M | 33,000 | 0.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.6M | 264,237 | 0.4% |